Mr Napoleon Prestoza Oliveros Jr, RPT | |
7 Keeler Ave, Moravia, NY 13118-3688 | |
(315) 497-0440 | |
Not Available |
Full Name | Mr Napoleon Prestoza Oliveros Jr |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 7 Keeler Ave, Moravia, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780176099 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 038232-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Napoleon Prestoza Oliveros Jr, RPT 24 Kellogg Rd Apt 30, Cortland, NY 13045-3179 Ph: (347) 283-6977 | Mr Napoleon Prestoza Oliveros Jr, RPT 7 Keeler Ave, Moravia, NY 13118-3688 Ph: (315) 497-0440 |
News Archive
The Lupus Foundation of America, Inc. (LFA) congratulates Insoo Kang, M.D., Associate Professor of Medicine, Yale University for being selected to receive a $1.2 million research grant from the U.S. Department of Defense's (DoD) Congressionally Directed Peer Reviewed Medical Research Program (PRMRP). The DoD award will fund a three-year study that will investigate whether and why lupus patients make more of the chemical interleukin (IL-27), which causes decreased generation of T cells and is known to play an important role in autoimmunity and lupus.
"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.
AcquiSci Inc., today announced it has received an award from the Hackensack University Medical Center to research AcquiSci's patented d-OSAB technology as a device-based approach to modulating inflammation.
Adolor Corporation today reported a net loss of approximately $11.1 million, or ($0.24) per basic and diluted share, for the three months ended September 30, 2009 compared to a net loss of $13.3 million, or ($0.29) per basic and diluted share, for the three months ended September 30, 2008.
Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon - including pancreas, stomach, biliary and esophageal cancers. This is one of more than 100 Mayo Clinic studies being presented at Digestive Disease Week 2009 in Chicago, May 30 - June 4.
› Verified 5 days ago
Susan Lipinoga, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 Van Pelt Ln, Moravia, NY 13118 Phone: 607-275-6537 |